Acne scars: pathogenesis, classification and treatment

Gabriella Fabbrocini, M C Annunziata, V D'Arco, V De Vita, G Lodi, M C Mauriello, F Pastore, G Monfrecola, Gabriella Fabbrocini, M C Annunziata, V D'Arco, V De Vita, G Lodi, M C Mauriello, F Pastore, G Monfrecola

Abstract

Acne has a prevalence of over 90% among adolescents and persists into adulthood in approximately 12%-14% of cases with psychological and social implications. Possible outcomes of the inflammatory acne lesions are acne scars which, although they can be treated in a number of ways, may have a negative psychological impact on social life and relationships. The main types of acne scars are atrophic and hypertrophic scars. The pathogenesis of acne scarring is still not fully understood, but several hypotheses have been proposed. There are numerous treatments: chemical peels, dermabrasion/microdermabrasion, laser treatment, punch techniques, dermal grafting, needling and combined therapies for atrophic scars: silicone gels, intralesional steroid therapy, cryotherapy, and surgery for hypertrophic and keloidal lesions. This paper summarizes acne scar pathogenesis, classification and treatment options.

Figures

Figure 1
Figure 1
Acne scars subtypes.
Figure 2
Figure 2
Icepick scars.
Figure 3
Figure 3
Boxcar scars.
Figure 4
Figure 4
TCA Cross: patient before the treatment.
Figure 5
Figure 5
TCA Cross: patient after the treatment.
Figure 6
Figure 6
Needling: the procedure.
Figure 7
Figure 7
Needling: patient before the treatment.
Figure 8
Figure 8
Needling: patient after the treatment.

References

    1. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. Journal of Investigative Dermatology. 2009;129(9):2136–2141.
    1. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. American Journal of Clinical Dermatology. 2006;7(5):281–290.
    1. Capitanio B, Sinagra JL, Bordignon V, Fei PC, Picardo M, Zouboulis CC. Underestimated clinical features of postadolescent acne. Journal of the American Academy of Dermatology. 2010;63(5):782–788.
    1. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clinical and Experimental Dermatology. 1994;19(4):303–308.
    1. Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. British Medical Journal. 1979;1(6171):1109–1110.
    1. Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Experimental Dermatology. 2009;18(10):821–832.
    1. Zouboulis CC. Acne and sebaceous gland function. Clinics in Dermatology. 2004;22(5):360–366.
    1. Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. Journal of Molecular Medicine. 2006;84(1):75–87.
    1. Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5α-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. British Journal of Dermatology. 2007;156(3):428–432.
    1. Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes and Infection. 2006;8(8):2195–2205.
    1. Kim J, Ochoa M-T, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Journal of Immunology. 2002;169(3):1535–1541.
    1. Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatologic Surgery. 2009;35(2):171–181.
    1. Cowin AJ, Brosnan MP, Holmes TM, Ferguson MWJ. Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse. Developmental Dynamics. 1998;212(3):385–393.
    1. Martin P, Leibovich SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends in Cell Biology. 2005;15(11):599–607.
    1. Holland DB, Jeremy AHT, Roberts SG, Seukeran DC, Layton AM, Cunliffe WJ. Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar. British Journal of Dermatology. 2004;150(1):72–81.
    1. Stadelmann WK, Digenis AG, Tobin GR. Physiology and healing dynamics of chronic cutaneous wounds. American Journal of Surgery. 1998;176(2A):26S–38S.
    1. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatologic Surgery. 2005;31(6):674–686.
    1. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. International Journal of Biochemistry and Cell Biology. 2004;36(6):1031–1037.
    1. Chivot M, Pawin H, Beylot C, et al. Acne scars: epidemiology, physiopathology, clinical features and treatment. Annales de Dermatologie et de Venereologie. 2006;133(10):813–824.
    1. Jacob CI, Dover JS, Kaminer MS. Acne scarring: a classification system and review of treatment options. Journal of the American Academy of Dermatology. 2001;45(1):109–117.
    1. Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatologic Surgery. 2006;32(12):1458–1466.
    1. Goodman GJ, Baron JA. Postacne scarring—a quantitative global scarring grading system. Journal of Cosmetic Dermatology. 2006;5(1):48–52.
    1. Dreno B, Khammari A, Orain N, et al. ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology. 2006;214(1):46–51.
    1. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatologic Surgery. 1999;25(8):631–638.
    1. Ghersetich I, Brazzini B, Lotti T. Chemical peeling. In: Lotti TM, Katsambas AD, editors. European Handbook of Dermatological Treatments. 2nd edition. Berlin, Germany: Springer; 2003.
    1. Ghersetich I, Teofoll P, Gantcheva M, Ribuffo M, Puddu P. Chemical peeling: how, when, why? Journal of the European Academy of Dermatology and Venereology. 1997;8(1):1–11.
    1. Landau M. Chemical peels. Clinics in Dermatology. 2008;26(2):200–208.
    1. Goodman GJ. Management of post-acne scarring: what are the options for treatment? American Journal of Clinical Dermatology. 2000;1(1):3–17.
    1. Goodman GJ. Postacne scarring: a review of its pathophysiology and treatment. Dermatologic Surgery. 2000;26(9):857–871.
    1. Bernstein EF, Lee J, Brown DB, Yu R, Van Scott E. Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin. Dermatologic Surgery. 2001;27(5):429–433.
    1. Javaheri SM, Handa S, Kaur I, Kumar B. Safety and efficacy of glycolic acid facial peel in Indian women with melasma. International Journal of Dermatology. 2001;40(5):354–357.
    1. Becker FF, Langford FPJ, Rubin MG, Speelman P. A histological comparison of 50% and 70% glycolic acid peels using solutions with various pHs. Dermatologic Surgery. 1996;22(5):463–465.
    1. Rook A, Wilkinson DS, Ebling FJG. Textbook of Dermatology. Oxford, UK: Blackwell Scientific; 1972.
    1. Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion and alpha hydroxy acids. Journal of the American Academy of Dermatology. 1984;11(5):867–879.
    1. Lynch BS, Delzell ES, Bechtel DH. Toxicology review and risk assessment of resorcinol: thyroid effects. Regulatory Toxicology and Pharmacology. 2002;36(2):198–210.
    1. Barbaud A, Modiano P, Cocciale M, Reichert S, Schmutz J-L. The topical application of resorcinol can provoke a systemic allergic reaction. British Journal of Dermatology. 1996;135(6):1014–1015.
    1. Griffin TD, Van Scott EJ, Maddin S. The use of pyruvic acid as a chemical peeling agent. Journal of Dermatologic Surgery & Oncology. 1989;15:p. 1316.
    1. Monheit GD. Medium-depth combination peels. Dermatologic Therapy. 2000;13(2):183–191.
    1. Van Scott EJ, Yu RJ. Alpha hydroxy acids: therapeutic potentials. Canadian Journal of Dermatology. 1989;1(5):108–112.
    1. Berardesca E, Cameli N, Primavera G, Carrera M. Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. Dermatologic Surgery. 2006;32(4):526–531.
    1. Unna PG. Therapeutiques generales des maladies de la peau. 1882.
    1. Lazo ND, Meine JG, Downing DT. Lipids are covalently attached to rigid corneocyte protein envelopes existing predominantly as β-sheets: a solid-state nuclear magnetic resonance study. Journal of Investigative Dermatology. 1995;105(2):296–300.
    1. Swinehart JM. Salicylic acid ointment peeling of the hands and forearms: effective nonsurgical removal of pigmented lesions and actinic damage. Journal of Dermatologic Surgery and Oncology. 1992;18(6):495–498.
    1. Imayama S, Ueda S, Isoda M. Histologic changes in the skin of hairless mice following peeling with salicylic acid. Archives of Dermatology. 2000;136(11):1390–1395.
    1. Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatologic Surgery. 1999;25(1):18–22.
    1. Swinehart JM. Salicylic acid ointment peeling of the hands and forearms: effective nonsurgical removal of pigmented lesions and actinic damage. Journal of Dermatologic Surgery and Oncology. 1992;18(6):495–498.
    1. Fabbrocini G, De Padova MP, Tosti A. Chemical peels: what's new and what isn't new but still works well. Facial Plastic Surgery. 2009;25(5):329–336.
    1. Dinner MI, Artz JS. The art of the trichloroacetic acid chemical peel. Clinics in Plastic Surgery. 1998;25(1):53–62.
    1. Slavin JW. Trichloroacetic acid peels. Aesthetic Surgery Journal. 2004;24(5):469–470.
    1. Al-Waiz MM, Al-Sharqi AI. Medium-depth chemical peels in the treatment of acne scars in dark-skinned individuals. Dermatologic Surgery. 2002;28(5):383–387.
    1. Lee JB, Chung WG, Kwahck H, Lee KH, Monheit G. Focal treatment of acne scars with trichloroacetic acid: Chemical reconstruction of skin scars method. Dermatologic Surgery. 2002;28(11):1017–1021.
    1. Fabbrocini G, Cacciapuoti S, Fardella N, Pastore F, Monfrecola G. CROSS technique: chemical reconstruction of skin scars method. Dermatologic Therapy. 2008;21(3):S29–S32.
    1. Yug A, Lane JE, Howard MS, Kent DE. Histologic study of depressed acne scars treated with serial high-concentration (95%) trichloroacetic acid. Dermatologic Surgery. 2006;32(8):985–990.
    1. Alkhawam L, Alam M. Dermabrasion and microdermabrasion. Facial Plastic Surgery. 2009;25(5):301–310.
    1. Shim EK, Barnette D, Hughes K, Greenway HT. Microdermabrasion: a clinical and histopathologic study. Dermatologic Surgery. 2001;27(6):524–530.
    1. Freedman BM, Rueda-Pedraza E, Waddell SP. The epidermal and dermal changes associated with microdermabrasion. Dermatologic Surgery. 2001;27(12):1031–1034.
    1. Shpall R, Beddingfield FC, III, Watson D, Lask GP. Microdermabrasion: a review. Facial Plastic Surgery. 2004;20(1):47–50.
    1. Tsai R-Y, Wang C-N, Chan H-L. Aluminum oxide crystal microdermabrasion: a new technique for treating facial scarring. Dermatologic Surgery. 1995;21(6):539–542.
    1. Lloyd JR. The use of microdermabrasion for acne: a pilot study. Dermatologic Surgery. 2001;27(4):329–331.
    1. Mandy SH. Tretinoin in the preoperative and postoperative management of dermabrasion. Journal of the American Academy of Dermatology. 1986;15(4):888–889.
    1. Nelson S. An introduction to laser and laser-tissue interactions in dermatology. In: Kauvar ANB, editor. Principles and Practices in Cutaneous Laser Surgery. Boca Raton, Fla, USA: Taylor and Francis Group; 2005. p. 70.
    1. Smith KJ, Skelton HG, Graham JS, Hurst CG, Hackley BE., Jr. Increased smooth muscle actin, factor XIIIa, and vimentin-positive cells in the papillary dermis of carbon dioxide laser-debrided porcine skin. Dermatologic Surgery. 1997;23(10):891–895.
    1. Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatologic Surgery. 2008;34(3):301–305.
    1. Chan HHL, Manstein D, Yu CS, Shek S, Kono T, Wei WI. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers in Surgery and Medicine. 2007;39(5):381–385.
    1. Fife DJ, Fitzpatrick RE, Zachary CB. Complications of fractional CO2 laser resurfacing: four cases. Lasers in Surgery and Medicine. 2009;41(3):179–184.
    1. Avram MM, Tope WD, Yu T, Szachowicz E, Nelson JS. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers in Surgery and Medicine. 2009;41(3):185–188.
    1. Fournier N, Mordon S. Nonablative remodeling with a 1,540 nm erbium:glass laser. Dermatologic Surgery. 2005;31(9):1227–1235.
    1. Friedman PM, Jih MH, Skover GR, Payonk GS, Kimyai-Asadi A, Geronemus RG. Treatment of atrophic facial acne scars with the 1064-nm Q-switched Nd:YAG laser: six-month follow-up study. Archives of Dermatology. 2004;140(11):1337–1341.
    1. Lipper GM, Perez M. Nonablative acne scar reduction after a series of treatments with a short-pulsed 1,064-nm Neodymium:YAG laser. Dermatologic Surgery. 2006;32(8):998–1006.
    1. Bhatia AC, Dover JS, Arndt KA, Stewart B, Alam M. Patient satisfaction and reported long-term therapeutic efficacy associated with 1,320 nm Nd:YAG laser treatment of acne scarring and photoaging. Dermatologic Surgery. 2006;32(3):346–352.
    1. Tanzi EL, Alster TS. Comparison of a 1450-nm diode laser and a 1320-nm Nd:YAG laser in the treatment of atrophic facial scars: a prospective clinical and histologic study. Dermatologic Surgery. 2004;30(2):152–157.
    1. Alster TS, Lupton JR. Are all infrared lasers equally effective in skin rejuvenation. Seminars in Cutaneous Medicine and Surgery. 2002;21(4):274–279.
    1. Hasegawa T, Matsukura T, Mizuno Y, Suga Y, Ogawa H, Ikeda S. Clinical trial of a laser device called fractional photothermolysis system for acne scars. Journal of Dermatology. 2006;33(9):623–627.
    1. Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatologic Surgery. 2008;34(3):301–305.
    1. Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatologic Surgery. 2007;33(3):295–299.
    1. Hantash BM, Bedi VP, Kapadia B, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers in Surgery and Medicine. 2007;39(2):96–107.
    1. Chapas AM, Brightman L, Sukal S, et al. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing. Lasers in Surgery and Medicine. 2008;40(6):381–386.
    1. Waibel J, Beer K, Narurkar V, Alster T. Preliminary observations on fractional ablative resurfacing devices: clinical impressions. Journal of Drugs in Dermatology. 2009;8(5):481–485.
    1. Hantash BM, Bedi VP, Chan KF, Zachary CB. Ex vivo histological characterization of a novel ablative fractional resurfacing device. Lasers in Surgery and Medicine. 2007;39(2):87–95.
    1. Hantash BM, Bedi VP, Kapadia B, et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers in Surgery and Medicine. 2007;39(2):96–107.
    1. Alster TS, West TB. Resurfacing of atrophic facial acne scars with a high-energy, pulsed carbon dioxide laser. Dermatologic Surgery. 1996;22(2):151–155.
    1. Goodman GJ. Postacne scarring: a review of its pathophysiology and treatment. Dermatologic Surgery. 2000;26(9):857–871.
    1. Koo SH, Yoon ES, Ahn DS, Park SH. Laser punch-out for acne scars. Aesthetic Plastic Surgery. 2001;25(1):46–51.
    1. Grevelink JM, White VR. Concurrent use of laser skin resurfacing and punch excision in the treatment of facial acne scarring. Dermatologic Surgery. 1998;24(5):527–530.
    1. Matsuoka LY. Acne and related disorders. Clinics in Plastic Surgery. 1993;20(1):35–41.
    1. Ellis DA, Michell MJ. Surgical treatment of acne scarring: non-linear scar revision. Journal of Otolaryngology. 1987;16(2):116–119.
    1. Trimble JR. Dermal overgrafting in dermatology. Journal of Dermatologic Surgery and Oncology. 1983;9(12):987–993.
    1. Burres SA. Recollagenation of acne scars. Dermatologic Surgery. 1996;22(4):364–367.
    1. Besecker B, Hart CG. A new treatment option for acne scars: allograft dermis. Dermatology nursing / Dermatology Nurses" Association. 1999;11(2):111–114.
    1. Ellenbogen R. Invited comment on autologous fat injection. Annals of Plastic Surgery. 1990;24:p. 297.
    1. Goodman GJ. Postacne scarring: a review of its pathophysiology and treatment. Dermatologic Surgery. 2000;26(9):857–871.
    1. Fernandes D. Minimally invasive percutaneous collagen induction. Oral and Maxillofacial Surgery Clinics of North America. 2005;17(1):51–63.
    1. Fabbrocini G, Fardella N, Monfrecola A, Proietti I, Innocenzi D. Acne scarring treatment using skin needling. Clinical and Experimental Dermatology. 2009;34(8):874–879.
    1. Kang WH, Kim YJ, Pyo WS, Park SJ, Kim JH. Atrophic acne scar treatment using triple combination therapy: dot peeling, subcision and fractional laser. Journal of Cosmetic and Laser Therapy. 2009;11(4):212–215.
    1. Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatologic Surgery. 2007;33(11):1291–1302.
    1. Mustoe TA, Cooter RD, Gold MH, et al. International clinical recommendations on scar management. Plastic and Reconstructive Surgery. 2002;110(2):560–571.
    1. Kelly AP. Medical and surgical therapies for keloids. Dermatologic Therapy. 2004;17(2):212–218.
    1. Nemeth AJ. Keloids and hypertrophic scars. Journal of Dermatologic Surgery and Oncology. 1993;19(8):738–746.
    1. Atiyeh BS. Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plastic Surgery. 2007;31(5):468–492.
    1. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Archives of Dermatology. 2002;138(9):1149–1155.
    1. Boutli-Kasapidou F, Tsakiri A, Anagnostou E, Mourellou O. Hypertrophic and keloidal scars: an approach to polytherapy. International Journal of Dermatology. 2005;44(4):324–327.
    1. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. Journal of Dermatologic Surgery and Oncology. 1993;19(6):529–534.
    1. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. British Journal of Dermatology. 1994;130(4):498–501.
    1. Apfelberg DB, Maser MR, Lash H. Preliminary results of argon and carbon dioxide laser treatment of keloid scars. Lasers in Surgery and Medicine. 1984;4(3):283–290.
    1. Castro DJ, Abergel RP, Meeker C. Effects of the Nd:YAG laser on DNA synthesis and collagen production in human skin fibroblast cultures. Annals of Plastic Surgery. 1983;11(3):214–222.
    1. Norris JEC. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plastic and Reconstructive Surgery. 1991;87(1):44–53.
    1. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Annals of Plastic Surgery. 1991;27(2):164–178.
    1. Sherman R, Rosenfeld H. Experience with the Nd:YAG laser in the treatment of keloid scars. Annals of Plastic Surgery. 1988;21(3):231–235.
    1. Kuo Y-R, Wu W-S, Jeng S-F, et al. Activation of ERK and p38 kinase mediated keloid fibroblast apoptosis after flashlamp pulsed-dye laser treatment. Lasers in Surgery and Medicine. 2005;36(1):31–37.
    1. Kuo Y-R, Wu W-S, Jeng S-F, et al. Suppressed TGF-β1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment. Lasers in Surgery and Medicine. 2005;36(1):38–42.
    1. Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet. 1995;345(8959):1198–1200.
    1. Alster T. Laser scar revision: Comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids. Dermatologic Surgery. 2003;29(1):25–29.
    1. Alster TS, Nanni CA. Pulsed dye laser treatment of hypertrophic burn scars. Plastic and Reconstructive Surgery. 1998;102(6):2190–2195.
    1. Alster T, Zaulyanov-Scanlon L. Laser scar revision: a review. Dermatologic Surgery. 2007;33(2):131–140.
    1. Manuskiatti W, Wanitphakdeedecha R, Fitzpatrick RE. Effect of pulse width of a 595-nm flashlamp-pumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars. Dermatologic Surgery. 2007;33(2):152–161.
    1. Dierickx C, Goldman MP, Fitzpatrick RE, Alster TS. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plastic and Reconstructive Surgery. 1995;95(1):84–92.
    1. Bowes LE, Nouri K, Berman B, et al. Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: a comparative study. Dermatologic Surgery. 2002;28(8):714–719.
    1. Manuskiatti W, Wanitphakdeedecha R, Fitzpatrick RE. Effect of pulse width of a 595-nm flashlamp-pumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars. Dermatologic Surgery. 2007;33(2):152–161.
    1. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatologic Surgery. 1995;21(8):685–687.
    1. Riedel F, Hormann K. Plastic surgery of skin defects in the face. Principles and prospective. HNO. 2005;53(12):1020–1036.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi